Thermolysin Stabilization via Salt Concentration Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Thermolysin, a thermostable neutral metalloproteinase, is unstable in aqueous solutions, leading to precipitation and reduced solubility, which complicates its use and storage due to its tendency to form autoproteolytic fragments and low solubility, especially when used in blends with other enzymes for tissue dissociation.

Innovation Solution

Thermolysin is first dissolved in a buffer with low ion concentration, followed by the addition of a further salt to stabilize the enzyme, forming a solution that remains clear and homogeneous for an extended period by reducing the tendency of thermolysin to precipitate, allowing for higher concentrations and prolonged stability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of operation

If thermolysin is dissolved in aqueous solution, then the enzyme becomes available for use, but it precipitates and loses stability

Engineering Contradiction:
Improveavailability for useVSAvoidstability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent applies parameter changes by systematically varying salt concentration, pH, and temperature to identify optimal conditions for thermolysin stability. Specifically, it uses buffers at pH 7.5-8.5 with salt concentrations of 0.5-2.0 M (particularly NaCl or KCl) to maintain the enzyme in solution and prevent precipitation, thereby resolving the contradiction between availability and stability.

Inventive Principle:
Principle #35Parameter changes

2Loss of time

If thermolysin is stored in aqueous solution, then it can be used immediately, but it forms autoproteolytic fragments and reduces solubility

Engineering Contradiction:
Improveimmediate useVSAvoidautoproteolytic fragments
Core Design Contradiction:
Loss of timeVSLoss of substance

Solution Approach 1:

The patent applies preliminary anti-action by pre-establishing protective conditions before autoproteolysis can occur. It uses specific buffer systems with controlled pH (7.5-8.5) and high salt concentrations (0.5-2.0 M) to prevent the formation of autoproteolytic fragments in advance, allowing the enzyme to be stored in solution without degradation and ready for immediate use.

Inventive Principle:
Principle #9Preliminary anti-action

3Productivity

If thermolysin is used in blends with other enzymes, then tissue dissociation effectiveness increases, but stability and solubility decrease

Engineering Contradiction:
Improvetissue dissociation effectivenessVSAvoidstability and solubility
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies universality by creating a buffer system that serves multiple functions simultaneously: it maintains pH (7.5-8.5), provides ionic strength (0.5-2.0 M salt), prevents precipitation, and stabilizes thermolysin in enzyme blends. This multi-functional buffer composition enables thermolysin to maintain stability and solubility when combined with other enzymes like collagenase for tissue dissociation applications.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method allows for the preparation of thermolysin solutions that remain stable and homogeneous for several hours, enabling effective storage, transport, and blending with other enzymes, such as collagenase, for tissue dissociation applications.

Implementation Method 1

Thermolysin is first dissolved in a buffer with low ion concentration

Methodology Applied
Scientific EffectDissolution: Solvation

Implementation Method 2

followed by the addition of a further salt to stabilize the enzyme, forming a solution that remains clear and homogeneous

Methodology Applied
Scientific EffectDissociation: Electrolyte

Data Source

PatentUS9574186B2Stabilization of thermolysin in aqueous solution
Publication Date: 2017.02.21 ROCHE DIAGNOSTICS OPERATIONS INC
  • US9574186B2 patent drawing
  • US9574186B2 patent drawing
  • US9574186B2 patent drawing

AI summary

The present invention deals with the proteolytic enzyme thermolysin which tends to be unstable in aqueous solution. The invention provides methods and compositions to enhance the stability of dissolved thermolysin in aqueous solution. Thermolysin, crude thermolysin or a lyophilisate containing thermolysin and one or more salts, is contacted with an aqueous buffer with a low salt concentration and a first solution is formed. Subsequently, a further salt in solid form is added and dissociated, thereby forming a second solution comprising thermolysin in a stabilized form.